Injectable for Cosmetic Surgery Market to Surpass US$ 243.0 Billion by 2031, Registering 20.6% CAGR on Strong Aesthetic Demand

Market Overview

The global Injectable for Cosmetic Surgery market was valued at US$ 66.71 billion in 2024 and is projected to expand dramatically to US$ 243.02 billion by 2031, registering a robust CAGR of 20.6% during the forecast period 2025-2031.

According to the latest report published by QY Research, titled "Injectable for Cosmetic Surgery Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031", the market is entering a high-growth phase driven by the global shift toward minimally invasive cosmetic procedures, growing aesthetic awareness, and rapid advancements in injectable technologies.

Get Full PDF Sample Copy of the Report: (Including Full TOC, Tables & Charts): https://qyresearch.in/request-sample/medical-devices-consumables-global-injectable-for-cosmetic-surgery-market-insights-industry-share-sales-projections-and-demand-outlook-2025-2031

Industry Definition and Background -

Injectables for cosmetic surgery include botulinum toxins, dermal fillers, soft tissue fillers, and other injectable aesthetic products used to enhance facial and body appearance without invasive surgical intervention. These products are widely applied for wrinkle reduction, facial contouring, volume restoration, jawline enhancement, and non-surgical facial rejuvenation.

Cosmetic surgery and aesthetic medicine are increasingly favored in urban populations, where rising disposable income, lifestyle changes, and social media influence have amplified demand for appearance-enhancing treatments. Injectable procedures, in particular, are gaining popularity due to shorter recovery times, lower procedural risk, and natural-looking outcomes compared with traditional surgical methods.

Key Growth Drivers -

Several structural and socioeconomic factors are accelerating growth in the injectable cosmetic surgery market:

Strong global preference for minimally invasive aesthetic procedures

Rising urbanization and aesthetic consciousness, especially among younger and middle-aged populations

Technological advancements in injectable formulations, improving longevity, safety, and precision

Expansion of dermatology clinics and beauty centers worldwide

Increasing medical tourism, particularly in Asia Pacific and parts of Europe

The market is also supported by the broader expansion of the global medical devices sector, which was valued at approximately US$ 603 billion in 2023 and continues to grow steadily. Global healthcare spending now accounts for nearly 10% of global GDP, creating a favorable environment for advanced aesthetic and cosmetic solutions.

Market Scope and Research Coverage -

This report provides a comprehensive analysis of the global Injectable for Cosmetic Surgery market, combining quantitative market sizing with qualitative insights. Market estimates and forecasts are presented in revenue terms (US$ millions), with 2024 as the base year, historical data spanning 2020-2024, and projections through 2031.

The study evaluates market performance across regions, product types, applications, and leading companies, offering a detailed view of current trends and future opportunities.

Regional Market Insights -

North America dominates the global market, supported by high procedure volumes, advanced clinical infrastructure, and strong presence of leading aesthetic brands.

Europe represents a mature and innovation-driven market, with high adoption of dermal fillers and botulinum toxin products.

Asia Pacific is the fastest-growing region, driven by expanding beauty consciousness, growing middle-class populations, and strong demand in China, South Korea, India, and Japan.

South America and the Middle East & Africa are emerging markets, benefiting from expanding private healthcare sectors and aesthetic tourism.

Competitive Landscape -

The injectable cosmetic surgery market is highly competitive, with pharmaceutical, biotechnology, and medical aesthetics companies focusing on product innovation, clinical efficacy, branding, and geographic expansion.

Key companies profiled in the report include:

► AbbVie
► Galderma
► Merz
► LG Life Sciences
► Medytox
► HUGEL
► Croma-Pharma
► Bloomage Bio
► Teoxane
► Sinclair
► Haohai Biological
► Prollenium
► Caregen

The report provides detailed analysis of company market share, competitive ranking, product portfolios, and strategic developments.

Market Segmentation Highlights -

By Type:

Botulinum Toxin
Soft Tissue Fillers
Dermal Fillers
Others

By Application:

Hospitals
Dermatology Clinics
Beauty Centers
Others

Each segment is analyzed in terms of revenue contribution, growth potential, and adoption trends.

Reasons to Procure this Report: -

►The research would help top administration/policymakers/professionals/product advancements/sales managers and stakeholders in this market in the following ways.

►The report provides Injectable for Cosmetic Surgery market revenues at the worldwide, regional, and country-level with a complete analysis to 2028 permitting companies to analyze their market share and analyze projections, and find new markets to aim.

►The research includes the Injectable for Cosmetic Surgery market split by different types, applications, technologies, and end-uses. This segmentation helps leaders plan their products and finances based on the upcoming development rates of each segment.

►Injectable for Cosmetic Surgery market analysis benefits investors by knowing the scope and position of the market giving them information on key drivers, challenges, restraints, and expansion chances of the market and moderate threats.

►This report would help to understand competition better with a detailed analysis and key strategies of their competitors and plan their position in the business.

►The study helps evaluate Injectable for Cosmetic Surgery business predictions by region, key countries, and top companies' information to channel their investments.

Key questions answered in the report include:

►This Injectable for Cosmetic Surgery report gives all the information about the industry analysis, revenue, and overview, of this market.

►What will be the rate of increase in Injectable for Cosmetic Surgery market size and growth rate by the end of the forecast period?

►What are the major global Injectable for Cosmetic Surgery market trends influencing the development of the market?

►What are the vital results of SWOT analysis of the major players operating in the Injectable for Cosmetic Surgery market?

►What are the potential growth opportunities and threats faced by Major competitors in the Injectable for Cosmetic Surgery market?

►What are the market opportunities and threats faced by vendors in the Global Injectable for Cosmetic Surgery market?

Request for Pre-Order / Enquiry Link: https://qyresearch.in/pre-order-inquiry/medical-devices-consumables-global-injectable-for-cosmetic-surgery-market-insights-industry-share-sales-projections-and-demand-outlook-2025-2031

Table of Contents - Major Key Points:

1 Injectable for Cosmetic Surgery Market Overview
1.1 Product Definition
1.2 Injectable for Cosmetic Surgery by Type
1.2.1 Global Injectable for Cosmetic Surgery Market Value by Type (2020-2031)
1.2.2 Botulinum Toxin
1.2.3 Soft Tissue Fillers
1.2.4 Dermal Fillers
1.2.5 Others
1.3 Injectable for Cosmetic Surgery by Application
1.3.1 Global Injectable for Cosmetic Surgery Market Value by Application 2020-2031)
1.3.2 Hospitals
1.3.3 Dermatology Clinics
1.3.4 Beauty Centers
1.3.5 Othes
1.4 Global Injectable for Cosmetic Surgery Revenue (2020-2031)
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Key Insights
2.1 Key Emerging Trends
2.2 Key Developments - Mergers Acquisitions, New Product Launches, Collaborations, Partnerships and Joint Ventures
2.3 Latest Technological Advancements
2.4 Insights on Regulatory Scenarios
2.5 Porters Five Forces Analysis
3 Players Competitive Analysis
3.1 Global Injectable for Cosmetic Surgery Revenue by Player (2020-2025)
3.2 Injectable for Cosmetic Surgery Company Evaluation Quadrant
3.3 Industry Rank
3.3.1 Global Key Players of Injectable for Cosmetic Surgery, Industry Ranking, 2023 VS 2024
3.3.2 Global Injectable for Cosmetic Surgery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3.3 Global Injectable for Cosmetic Surgery Market Concentration Rate
3.3.4 Global 5 and 10 Largest Injectable for Cosmetic Surgery Players Market Share by Revenue
3.4 Injectable for Cosmetic Surgery Market: Overall Company Footprint Analysis
3.4.1 Injectable for Cosmetic Surgery Market: Region Footprint
3.4.2 Injectable for Cosmetic Surgery Market: Company Product Type Footprint
3.4.3 Injectable for Cosmetic Surgery Market: Company Product Application Footprint
3.4.4 Global Key Players of Injectable for Cosmetic Surgery, Date of Enter into This Industry
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
4 Players Profiles
4.1 AbbVie
4.1.1 AbbVie Company Details
4.1.2 AbbVie Business Overview
4.1.3 AbbVie Injectable for Cosmetic Surgery Introduction
4.1.4 AbbVie Revenue in Injectable for Cosmetic Surgery Business (2020-2025)
4.1.5 AbbVie Recent Development
4.2 Galderma
4.2.1 Galderma Company Details
4.2.2 Galderma Business Overview
4.2.3 Galderma Injectable for Cosmetic Surgery Introduction
4.2.4 Galderma Revenue in Injectable for Cosmetic Surgery Business (2020-2025)
4.2.5 Galderma Recent Development
4.3 LG Life Sciences
4.3.1 LG Life Sciences Company Details
4.3.2 LG Life Sciences Business Overview
4.3.3 LG Life Sciences Injectable for Cosmetic Surgery Introduction
4.3.4 LG Life Sciences Revenue in Injectable for Cosmetic Surgery Business (2020-2025)
4.3.5 LG Life Sciences Recent Development
4.4 Merz
4.4.1 Merz Company Details
4.4.2 Merz Business Overview
4.4.3 Merz Injectable for Cosmetic Surgery Introduction
4.4.4 Merz Revenue in Injectable for Cosmetic Surgery Business (2020-2025)
4.4.5 Merz Recent Development
4.5 Medytox
4.5.1 Medytox Company Details
4.5.2 Medytox Business Overview
4.5.3 Medytox Injectable for Cosmetic Surgery Introduction
4.5.4 Medytox Revenue in Injectable for Cosmetic Surgery Business (2020-2025)
4.5.5 Medytox Recent Development
4.6 HUGEL
4.6.1 HUGEL Company Details
4.6.2 HUGEL Business Overview
4.6.3 HUGEL Injectable for Cosmetic Surgery Introduction
4.6.4 HUGEL Revenue in Injectable for Cosmetic Surgery Business (2020-2025)
4.6.5 HUGEL Recent Development
4.7 Croma-Pharma
4.7.1 Croma-Pharma Company Details
4.7.2 Croma-Pharma Business Overview
4.7.3 Croma-Pharma Injectable for Cosmetic Surgery Introduction
4.7.4 Croma-Pharma Revenue in Injectable for Cosmetic Surgery Business (2020-2025)
4.7.5 Croma-Pharma Recent Development
4.8 Beijing IMEIK
4.8.1 Beijing IMEIK Company Details
4.8.2 Beijing IMEIK Business Overview
4.8.3 Beijing IMEIK Injectable for Cosmetic Surgery Introduction
4.8.4 Beijing IMEIK Revenue in Injectable for Cosmetic Surgery Business (2020-2025)
4.8.5 Beijing IMEIK Recent Development
4.9 Bloomage Bio
4.9.1 Bloomage Bio Company Details
4.9.2 Bloomage Bio Business Overview
4.9.3 Bloomage Bio Injectable for Cosmetic Surgery Introduction
4.9.4 Bloomage Bio Revenue in Injectable for Cosmetic Surgery Business (2020-2025)
4.9.5 Bloomage Bio Recent Development
4.10 Elravie (Humedix)
4.10.1 Elravie (Humedix) Company Details
4.10.2 Elravie (Humedix) Business Overview
4.10.3 Elravie (Humedix) Injectable for Cosmetic Surgery Introduction
4.10.4 Elravie (Humedix) Revenue in Injectable for Cosmetic Surgery Business (2020-2025)
4.10.5 Elravie (Humedix) Recent Development
4.11 Cleviel (Pharma Research Products)
4.11.1 Cleviel (Pharma Research Products) Company Details
4.11.2 Cleviel (Pharma Research Products) Business Overview
4.11.3 Cleviel (Pharma Research Products) Injectable for Cosmetic Surgery Introduction
4.11.4 Cleviel (Pharma Research Products) Revenue in Injectable for Cosmetic Surgery Business (2020-2025)
4.11.5 Cleviel (Pharma Research Products) Recent Development
4.12 Haohai Biological
4.12.1 Haohai Biological Company Details
4.12.2 Haohai Biological Business Overview
4.12.3 Haohai Biological Injectable for Cosmetic Surgery Introduction
4.12.4 Haohai Biological Revenue in Injectable for Cosmetic Surgery Business (2020-2025)
4.12.5 Haohai Biological Recent Development
4.13 Q.O.Fill (JW Pharmaceutical)
4.13.1 Q.O.Fill (JW Pharmaceutical) Company Details
4.13.2 Q.O.Fill (JW Pharmaceutical) Business Overview
4.13.3 Q.O.Fill (JW Pharmaceutical) Injectable for Cosmetic Surgery Introduction
4.13.4 Q.O.Fill (JW Pharmaceutical) Revenue in Injectable for Cosmetic Surgery Business (2020-2025)
4.13.5 Q.O.Fill (JW Pharmaceutical) Recent Development
4.14 Teoxane
4.14.1 Teoxane Company Details
4.14.2 Teoxane Business Overview
4.14.3 Teoxane Injectable for Cosmetic Surgery Introduction
4.14.4 Teoxane Revenue in Injectable for Cosmetic Surgery Business (2020-2025)
4.14.5 Teoxane Recent Development
4.15 Sinclair
4.15.1 Sinclair Company Details
4.15.2 Sinclair Business Overview
4.15.3 Sinclair Injectable for Cosmetic Surgery Introduction
4.15.4 Sinclair Revenue in Injectable for Cosmetic Surgery Business (2020-2025)
4.15.5 Sinclair Recent Development
4.16 Suneva Medical
4.16.1 Suneva Medical Company Details
4.16.2 Suneva Medical Business Overview
4.16.3 Suneva Medical Injectable for Cosmetic Surgery Introduction
4.16.4 Suneva Medical Revenue in Injectable for Cosmetic Surgery Business (2020-2025)
4.16.5 Suneva Medical Recent Development
4.17 CG Bio
4.17.1 CG Bio Company Details
4.17.2 CG Bio Business Overview
4.17.3 CG Bio Injectable for Cosmetic Surgery Introduction
4.17.4 CG Bio Revenue in Injectable for Cosmetic Surgery Business (2020-2025)
4.17.5 CG Bio Recent Development
4.18 SciVision Biotech
4.18.1 SciVision Biotech Company Details
4.18.2 SciVision Biotech Business Overview
4.18.3 SciVision Biotech Injectable for Cosmetic Surgery Introduction
4.18.4 SciVision Biotech Revenue in Injectable for Cosmetic Surgery Business (2020-2025)
4.18.5 SciVision Biotech Recent Development
4.19 Prollenium
4.19.1 Prollenium Company Details
4.19.2 Prollenium Business Overview
4.19.3 Prollenium Injectable for Cosmetic Surgery Introduction
4.19.4 Prollenium Revenue in Injectable for Cosmetic Surgery Business (2020-2025)
4.19.5 Prollenium Recent Development
4.20 Matex-Lab
4.20.1 Matex-Lab Company Details
4.20.2 Matex-Lab Business Overview
4.20.3 Matex-Lab Injectable for Cosmetic Surgery Introduction
4.20.4 Matex-Lab Revenue in Injectable for Cosmetic Surgery Business (2020-2025)
4.20.5 Matex-Lab Recent Development
4.21 Jingjia Medical
4.21.1 Jingjia Medical Company Details
4.21.2 Jingjia Medical Business Overview
4.21.3 Jingjia Medical Injectable for Cosmetic Surgery Introduction
4.21.4 Jingjia Medical Revenue in Injectable for Cosmetic Surgery Business (2020-2025)
4.21.5 Jingjia Medical Recent Development
4.22 Genoss
4.22.1 Genoss Company Details
4.22.2 Genoss Business Overview
4.22.3 Genoss Injectable for Cosmetic Surgery Introduction
4.22.4 Genoss Revenue in Injectable for Cosmetic Surgery Business (2020-2025)
4.22.5 Genoss Recent Development
4.23 Bohus BioTech
4.23.1 Bohus BioTech Company Details
4.23.2 Bohus BioTech Business Overview
4.23.3 Bohus BioTech Injectable for Cosmetic Surgery Introduction
4.23.4 Bohus BioTech Revenue in Injectable for Cosmetic Surgery Business (2020-2025)
4.23.5 Bohus BioTech Recent Development
4.24 Caregen
4.24.1 Caregen Company Details
4.24.2 Caregen Business Overview
4.24.3 Caregen Injectable for Cosmetic Surgery Introduction
4.24.4 Caregen Revenue in Injectable for Cosmetic Surgery Business (2020-2025)
4.24.5 Caregen Recent Development
5 Analysis by Region
5.1 Global Injectable for Cosmetic Surgery Market Size by Region
5.1.1 Global Injectable for Cosmetic Surgery Revenue by Region: 2020 VS 2024 VS 2031
5.1.2 Global Injectable for Cosmetic Surgery Revenue by Region (2020-2025)
5.1.3 Global Injectable for Cosmetic Surgery Revenue by Region (2026-2031)
5.1.4 Global Injectable for Cosmetic Surgery Revenue Market Share by Region (2020-2031)
5.2 North America Injectable for Cosmetic Surgery Revenue (2020-2031)
5.3 Europe Injectable for Cosmetic Surgery Revenue (2020-2031)
5.4 Asia-Pacific Injectable for Cosmetic Surgery Revenue (2020-2031)
5.5 South America Injectable for Cosmetic Surgery Revenue (2020-2031)
5.6 Middle East & Africa Injectable for Cosmetic Surgery Revenue (2020-2031)
6 Market Scenario by Region & Country
6.1 Global Injectable for Cosmetic Surgery Revenue by Region & Country: 2020 Versus 2024 Versus 2031
6.2 Global Injectable for Cosmetic Surgery Revenue by Region & Country (2020-2031)
6.3 North America Injectable for Cosmetic Surgery Market Facts & Figures by Country
6.3.1 North America Injectable for Cosmetic Surgery Revenue by Country: 2020 VS 2024 VS 2031
6.3.2 North America Injectable for Cosmetic Surgery Revenue by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe Injectable for Cosmetic Surgery Market Facts & Figures by Country
6.4.1 Europe Injectable for Cosmetic Surgery Revenue by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Injectable for Cosmetic Surgery Revenue by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Russia
6.5 Asia Pacific Injectable for Cosmetic Surgery Market Facts & Figures by Region
6.5.1 Asia Pacific Injectable for Cosmetic Surgery Market Size by Region: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Injectable for Cosmetic Surgery Revenue by Region (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 India
6.5.7 Australia
6.5.8 Taiwan
6.5.9 Indonesia
6.5.10 Thailand
6.5.11 Malaysia
6.5.12 Philippines
6.6 South America Injectable for Cosmetic Surgery Market Facts & Figures by Country
6.6.1 South America Injectable for Cosmetic Surgery Market Size by Country: 2020 VS 2024 VS 2031
6.6.2 South America Injectable for Cosmetic Surgery Revenue by Country
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Argentina
6.7 Middle East and Africa Injectable for Cosmetic Surgery Market Facts & Figures by Country
6.7.1 Middle East and Africa Injectable for Cosmetic Surgery Market Size by Country: 2020 VS 2024 VS 2031
6.7.2 Middle East and Africa Injectable for Cosmetic Surgery Revenue by Country
6.7.3 Turkey
6.7.4 Saudi Arabia
6.7.5 U.A.E
7 Segment by Type
7.1 Global Injectable for Cosmetic Surgery Revenue by Type (2020-2025)
7.2 Global Injectable for Cosmetic Surgery Revenue by Type (2026-2031)
7.3 Global Injectable for Cosmetic Surgery Revenue Market Share by Type (2020-2031)
8 Segment by Application
8.1 Global Injectable for Cosmetic Surgery Revenue by Application (2020-2025)
8.2 Global Injectable for Cosmetic Surgery Revenue by Application (2026-2031)
8.3 Global Injectable for Cosmetic Surgery Revenue Market Share by Application (2020-2031)
9 Industry Chain and Sales Channels Analysis
9.1 Injectable for Cosmetic Surgery Industry Chain Analysis
9.2 Injectable for Cosmetic Surgery Key Raw Materials
9.2.1 Key Raw Materials
9.2.2 Raw Materials Key Suppliers
9.3 Injectable for Cosmetic Surgery Production Mode & Process
9.4 Injectable for Cosmetic Surgery Sales and Marketing
9.4.1 Injectable for Cosmetic Surgery Sales Channels
9.4.2 Injectable for Cosmetic Surgery Distributors
9.5 Injectable for Cosmetic Surgery Customers
10 Research Findings and Conclusion
11 Appendix
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.1.1 Research Programs/Design
11.1.1.2 Market Size Estimation
11.1.1.3 Market Breakdown and Data Triangulation
11.1.2 Data Source
11.1.2.1 Secondary Sources
11.1.2.2 Primary Sources
11.2 Author Details
11.3 Disclaimer

About Us:

QYResearch established as a research firm in 2007 and have since grown into a trusted brand amongst many industries. Over the years, we have consistently worked toward delivering high-quality customized solutions for wide range of clients ranging from ICT to healthcare industries. With over 50,000 satisfied clients, spread over 80 countries, we have sincerely strived to deliver the best analytics through exhaustive research methodologies.

Contact Us:

Arshad Shaha | Marketing Executive

QY Research, INC.
315 Work Avenue, Raheja Woods,
Survey No. 222/1, Plot No. 25, 6th Floor,
Kayani Nagar, Yervada, Pune 411006, Maharashtra
Tel: +91-8669986909
Emails - arshad@qyrindia.com
Web - https://www.qyresearch.in

This release was published on openPR.